Episode 036: Hemophilia 101, Pt 1

In this episode, we break down the initial approach to the evaluation of a patient with a suspected bleeding disorder, particularly in regards to hemophilia, including standardized bleeding assessment tools, the basics of the coagulation cascade, and mixing studies.


The first step is taking a thorough bleeding history

The Fellow on Call Bleeding Assessment: 

  1. Mucosal bleeding working from nose down: epistaxis (did they need cauterization), gum bleeding, bleeding with tooth pulling, hematochezia, hematuria, menorrhagia or excessive post-partum bleeding

  2. Skin: Bruising, petechiae, telangiectasias 

  3. “Ortho bleeding”: spontaneous joint or muscle hematoma 

    Raises concern for hemophilia 

  4. Prior surgical or family history?

  5. Medications? 

Always clarify: are these issues lifelong?

The International Society for Thrombosis and Hemostasis scoring tool is useful for standardizing bleeding symptoms, and it can help you determine the likelihood that a patient has an underlying bleeding disorder.

Physical exam

Pay particular attention to: 

  • Assess skin for bruising or petechiae

  • Assess the fingertips

  • If having epistaxis, may need to have help to assess nostrils for anatomical issues (vessels)

  • Assess mucosal surfaces for telangiectasias which could point to a diagnosis of Hereditary Hemorrhagic Telangiectasia, a mimicker of bleeding disorders

  • Assess thighs and flanks for obvious signs of bruising/bleeding

We sort bleeding disorders into two large buckets

  • Platelet dysfunction → minor bleeding (i.e., mucosal bleeding, epistaxis) 

  • Factor deficiency → major bleeding (i.e., joint effusions, spontaneous ICH) 

The basic workup includes

  • CBC - to assess for low platelets 

  • Peripheral smear - rule out schistocytes (DIC)

  • CMP - to check for liver dysfunction or severe renal dysfunction/uremia which leads to platelet dysfunction 

  • PT/INR, aPTT, fibrinogen

  • Von Willebrand Panel

Coagulation Cascade

  • PT → measures the extrinsic pathway → factor 7 (lucky) 

  • PTT → measures the intrinsic pathway → factors 12, 11, 9, 8 (TENET)

  • Intrinsic and extrinsic pathway feed into the common pathway → factors 10, 5, 2, 1 (All dollar bills less than $20) 

If a patient has an abnormal PT/PTT, you must ask

Is it a lack of a necessary clotting factor or something interfering with the time it takes a clot to form?

You assess this with a mixing study

  • A mixing study combines equal parts of the patient’s plasma with control plasma. 

  • Mixing study corrects → deficiency of a coagulation factor 

  • Mixing study does not correct → antibody interfering with assay or the function of the factors in the coagulation cascade 

  • *To correct, the time must be in the normal range for the assay, not just slightly improved!

  • *The mixing study is assessed at time points 0 hr, 1 hr, 2 hr; the presence of an inhibitory may improve the time initially, but can then become longer again at time points 1hr and/or 2hr

After the mixing study, then you also need to know which of the factors is the issue! How to do this: 

  • Functional assays can be ordered to measure individual coagulation factor function.

  • Factor 11 – Hemophilia C

  • Factor 9 – Hemophilia B 

  • Factor 8 – Hemophilia A 

  • Understanding the coagulation cascade allows you know quickly know what to order


The crew behind the magic: 

  • Show outline: Ronak Mistry

  • Production and hosts: Ronak Mistry, Vivek Patel, Dan Hausrath

  • Editing: Vivek Patel

  • Shownotes, graphics, social media management: Ronak Mistry

Previous
Previous

Episode 037: Hemophilia 101, Pt 2

Next
Next

Episode 035: Lung Cancer Series, Pt. 12: NSCLC Capstone with Dr. Jack West (Con’t)